Trending intel short linkNo signup · Email subscription
32.7k following · GLP-1 / Drug Approval / China

Approval result of Hengrui Medicine's Retatrutide for marketing in China

Follow the marketing approval progress, approved indications, approval time and commercial preparation updates of Hengrui Medicine's GLP-1R/GIPR dual-target Retatrutide.

32.7k following61.9k views
By clicking “Confirm”, you acknowledge that you have read and agree to
/ /
Unlimited Free Public IntelligenceOnly key changes trigger emailsUnsubscribe anytime
Monitor official signalsTrack announcements, filings, company statements, prices, and investor updates.
AI summaryFilter repeated noise and provide concise conclusions with source confidence.
Notify only when usefulNo daily spam. You only get emailed when meaningful progress appears.